ArticleHaematologica2018

BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.

Klara Srutova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.